Welcome to our dedicated page for Cvs Health news (Ticker: CVS), a resource for investors and traders seeking the latest updates and insights on Cvs Health stock.
News about CVS Health Corporation (NYSE: CVS) covers developments across its roles in retail pharmacy, pharmacy benefit management, health insurance and health care delivery. Company press releases and related disclosures highlight how CVS Health communicates financial performance, strategic priorities, governance updates and community initiatives to investors, customers and the public.
Investors following CVS stock can find news on quarterly and full-year earnings announcements, financial guidance updates and Investor Day presentations. For example, CVS Health has issued press releases discussing results for specific quarters, updating full-year financial guidance and providing outlooks for future years, including projections for revenues, operating income, adjusted operating income, GAAP diluted earnings (loss) per share and adjusted EPS. These communications often appear in conjunction with Form 8-K filings that furnish the underlying press releases.
Corporate governance and leadership changes are another recurring news theme. CVS Health has announced Board decisions such as appointing its President and Chief Executive Officer, J. David Joyner, to the additional role of Chair of the Board, and it has used both press releases and Form 8-K filings to describe these actions and related Board structures.
Operational and community-focused news items describe how CVS Health engages with public health and local organizations. Examples include offering the measles-mumps-rubella (MMR) vaccine at select CVS Pharmacy and MinuteClinic locations in South Carolina during a measles outbreak, and the CVS Health Foundation’s grants to the American Diabetes Association to expand a maternal diabetes program in New York City. Other stories highlight investments in affordable housing projects and the company’s reported economic impact across U.S. states.
Visitors to this news page can review these types of announcements to understand how CVS Health presents its strategy, financial outlook, health services, community partnerships and responses to health challenges over time.
CVS Health Corporation (NYSE: CVS) announced its participation in the J.P. Morgan 39th Annual Healthcare Conference on January 12, 2021. Key executives will include President and CEO Larry Merlo, CFO Eva Boratto, and incoming CEO Karen Lynch, who will engage in a fireside chat at 10:50 a.m. ET. Additionally, Lynch will take part in a vaccine panel discussion at 12:45 AM ET on January 13, 2021. CVS Health continues to focus on improving healthcare accessibility and affordability.
CVS Health Corporation announced cash tender offers totaling $4.5 billion for three groups of senior notes: up to $1.5 billion for 2023 Notes, $1.049 billion for 2025 Notes, and $1.950 billion for 2028 Notes. The total consideration and reference yields for the notes were detailed in the press release. The offers are open to registered holders until January 6, 2021, and the early settlement date is December 22, 2020. CVS expects to accept validly tendered notes on a prorated basis due to maximum amounts being reached.
CVS Health has launched its COVID-19 vaccination program for long-term care facilities, addressing the needs of residents disproportionately affected by the pandemic. Starting December 21, CVS teams will administer the Pfizer vaccine in 12 states, aiming to vaccinate up to four million individuals across more than 40,000 facilities. The program will involve three visits per facility for each resident and staff member. CVS anticipates completing the vaccination efforts in about 12 weeks, with plans to expand availability to all pharmacy locations in the coming months.
CVS Health Corporation (CVS) announced an increase in the Aggregate Maximum Amount of its cash tender offers from $4 billion to $4.5 billion. The updated amounts for specific notes include $1.049 billion for 2025 Notes and $1.95 billion for 2028 Notes. The tender offers are aimed at holders of 2023, 2025, and 2028 Senior Notes. On December 21, 2020, the company will pay for notes validly tendered by December 18, 2020, with an early payment incentive of $30 per $1,000 principal amount. The expiration date has been shifted to January 6, 2021.
AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) for Aetna Life Insurance Company and its subsidiaries under CVS Health (CVS). The Long-Term Issuer Credit Ratings are also rated at 'a'. Aetna Health & Life Group's ratings reflect very strong balance sheet strength and robust operating performance. However, dividend payments exceeding $2 billion annually could impact capital. Notably, Aetna's Medicare Advantage membership growth has been strong, with 23.3 million individuals covered, while maintaining an industry-leading market share in Medicare Part D.
CVS Health has implemented time delay safe technology in all 79 Oklahoma CVS Pharmacy locations to combat pharmacy robberies and ensure safety. The technology, which delays access to controlled substances, has resulted in a 70% decline in robberies in Indianapolis stores since its introduction in 2015. In total, more than 15 states have adopted this measure, achieving a 50% reduction in similar incidents. The initiative is part of CVS's broader commitment to prevent opioid misuse and enhance community safety.
CVS Health (NYSE: CVS) has announced a commitment of nearly $3 million to enhance flu vaccine access for underserved communities. The initiative will allocate $2 million to the National Association of Free and Charitable Clinics to distribute flu vaccines, particularly in states like California, Florida, and Texas. Partnering with Bank of America and General Motors, the project aims to provide vouchers for free vaccines in cities such as Boston and Los Angeles. This initiative is critical as flu prevention remains vital during the ongoing COVID-19 pandemic.
CVS Health announced nearly $1.25 million in grants to support underserved communities in Ohio. This includes $1 million for telehealth services in collaboration with the National Association of Free and Charitable Clinics, and $100,000 for local food banks through Feeding America to provide meal kits. Additionally, the CVS Health Foundation will invest $150,000 in Cleveland Clinic's mobile health unit. This initiative expands healthcare access and addresses food insecurity amid the COVID-19 pandemic, following a previous $300,000 commitment from Aetna Better Health of Ohio.
CVS Health (NYSE: CVS) emphasizes the importance of flu vaccinations during National Influenza Vaccination Week (Dec. 6-12). With plans to administer 20 million flu shots this season, CVS urges individuals to get vaccinated, highlighting the dual challenge of flu and COVID-19. The company operates nearly 10,000 CVS Pharmacy and 1,100 MinuteClinic locations, providing accessible immunization options. Enhanced safety measures for patients and staff are in place, including temperature checks and PPE for providers. For flu shot appointments, visit cvs.com.
CVS Health has initiated cash tender offers for up to $4 billion in senior notes, including $1.5 billion of 4.000% and 3.700% senior notes due 2023, $1 billion of 4.100% and 3.875% senior notes due 2025, and $1.5 billion of 4.300% senior notes due 2028. These tender offers aim to refinance a portion of CVS Health's debt, potentially reducing its overall indebtedness. The offers allow holders to receive early tender payments if they act by December 18, 2020. Settlement dates for accepted notes are set for December 22, 2020, and January 7, 2021.